Transaction · 0000914190-26-000122

Kelderman Kim

Kelderman Kim, CEO, reported a transaction classified as return at BIO-TECHNE Corp involving 24324.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1621.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

returnSEC transaction code DCEO
TECHBIO-TECHNE Corp
Trade date
Aug 15, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded24.3k$0.00 per share
Holdings after1.62kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.6%1w ago +0.1%1d ago +0.2%
Returns since7d +0.2%30d +0.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
return
Code D
Identifier
0000914190-26-000122
Performance Stock Options (Right to Buy)
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 09:14 PM · 3d delay
Shares
24,324 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
1,621 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Fully exercisable.

  2. F2

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  3. F3

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 554 performance RSUs. The remainder of the performance RSUs were forfeited.

  4. F4

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,492 performance options. The remainder of the performance options were forfeited.

  5. F5

    Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.

  6. F6

    Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.

  7. F7

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 588 performance RSUs. The remainder of the performance RSUs were forfeited.

  8. F8

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,621 performance options. The remainder of the performance options were forfeited.

  9. F9

    Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

  10. F10

    Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  11. F11

    8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.

  12. F12

    Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.

  13. F13

    Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  14. F14

    11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.

  15. F15

    Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

Original filing · 0000914190-26-000122
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH